Carmustine implants costly in high-grade gliomas

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1620, 2008-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis

By Rogers Gabriel Garside Ruth Mealing Stuart Pitt Martin Anderson Rob Dyer Matthew Stein Ken Somerville Margaret

PharmacoEconomics, Vol. 26, Iss. 1, 2008-01 ,pp. : 33-44

Adis International

Access to resources Recommend Favorite

Antiangiogenic Therapy for High-Grade Gliomas

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 184-194

Bentham Science Publishers

Access to resources Recommend Favorite

Carmustine-impregnated wafers and their impact in the management of high-grade glioma

By La Rocca Renato V Rezazadeh Arash

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1325-1332

Informa Healthcare

Access to resources Recommend Favorite

Chemoresistance in High-Grade Gliomas: Relevance of Adenosine Signalling in Stem-Like Cells of Glioblastoma Multiforme

Current Drug Targets, Vol. 15, Iss. 10, 2014-09 ,pp. : 931-942

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term survival high for patients with low-grade gliomas

By Printz Carrie

Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. : 1913-1913

Blackwell Publishing

Access to resources Recommend Favorite